Internal Medicine, Medical Oncology · Indianapolis, IN
NPI
1922079474
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
7979 N Shadeland Ave, Ste 200
Indianapolis, IN, 46250
Phone (317) 621-4300
Groups this clinician bills Medicare through
Medicare paid, 2024
$37K
509 services
Medicare patients, 2024
298
Average age 74
Drug cost, 2024
$10.4M
975 prescriptions
Company payments, 2025
$4,147
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sumeet Bhatia was code 99204 (office e&m - new), 80 times for 80 patients. In total Sumeet Bhatia billed 509 services in 17 codes, and Medicare paid $37K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99204 Office E&M - New | Facility | 80 | 80 | $87.93 | $7,035 |
| 99214 Office E&M - Established | Facility | 77 | 68 | $67.55 | $5,201 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 55 | 53 | $12.23 | $673 |
| 99215 Office E&M - Established | Facility | 51 | 34 | $104.47 | $5,328 |
| 99232 Hospital E&M - Subsequent | Facility | 46 | 29 | $56.70 | $2,608 |
| 99205 Office E&M - New | Facility | 34 | 34 | $131.12 | $4,458 |
| 99214 Office E&M - Established | Office | 33 | 30 | $86.72 | $2,862 |
| 99213 Office E&M - Established | Facility | 24 | 23 | $43.43 | $1,042 |
| 99213 Office E&M - Established | Office | 17 | 16 | $64.96 | $1,104 |
| 99203 Office E&M - New | Facility | 15 | 15 | $59.31 | $890 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 14 | 14 | $12.23 | $171 |
| 99215 Office E&M - Established | Office | 12 | 11 | $133.25 | $1,599 |
By year: 2022 $44K for 575 services; 2023 $42K for 541 services; 2024 $37K for 509 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sumeet Bhatia prescribed most often to Medicare patients was Venclexta (Venetoclax), with 98 prescriptions and refills. In total Sumeet Bhatia wrote 975 Medicare prescriptions that cost $10.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Venclexta Venetoclax | 98 | 98 | 32 | $357K |
| Imbruvica Ibrutinib | 76 | 76 | 11 | $1.5M |
| Ondansetron Hcl Generic | 46 | 47 | 39 | $1,077 |
| Tagrisso Osimertinib Mesylate | 40 | 40 | Under 11 | $680K |
| Prochlorperazine Maleate Generic | 37 | 37 | 31 | $376 |
| Brukinsa Zanubrutinib | 35 | 35 | Under 11 | $444K |
| Sprycel Dasatinib | 33 | 33 | Under 11 | $277K |
| Revlimid Lenalidomide | 33 | 33 | Under 11 | $577K |
| Verzenio Abemaciclib | 32 | 32 | 13 | $475K |
| Acyclovir Generic | 30 | 34 | 11 | $248 |
| Pomalyst Pomalidomide | 29 | 29 | Under 11 | $577K |
| Braftovi Encorafenib | 28 | 28 | Under 11 | $290K |
| Mektovi Binimetinib | 20 | 20 | Under 11 | $273K |
| Alecensa Alectinib Hcl | 19 | 19 | Under 11 | $332K |
| Ibrance Palbociclib | 18 | 18 | Under 11 | $272K |
Brand drugs: 744 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sumeet Bhatia $4,147 ($4,147 in general payments such as food, travel and fees) from 4 companies. The largest payer was Avyxa Pharma, LLC with $3,789.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.